We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$281B
AUM Growth
-$2.86B
Cap. Flow
-$7.29B
Cap. Flow %
-2.6%
Top 10 Hldgs %
26.87%
Holding
10,979
New
1,821
Increased
3,804
Reduced
3,502
Closed
1,753

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.29B
2
NVDA icon
NVIDIA
NVDA
+$588M
3
BAC icon
Bank of America
BAC
+$289M
4
INTC icon
Intel
INTC
+$288M
5
UNP icon
Union Pacific
UNP
+$281M

Sector Composition

Rank Sector Weight
1 Technology 1.83%
2 Communication Services 1.58%
3 Consumer Discretionary 1.42%
4 Healthcare 0.84%
5 Financials 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C.WS.A
9151
DELISTED
Citigroup Inc
C.WS.A
$9K ﹤0.01%
194,246
+150,304
+342% +$15.6K
PGH
9152
PUT
DELISTED
Pengrowth Energy Corporation
PGH
$9K ﹤0.01%
14,200
+100
+0.7% +$74
CRIS icon
9153
Curis
CRIS
$3.86M
$8K ﹤0.01%
6
-22
-79% -$28.8K
AMRHW
9154
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$8K ﹤0.01%
18,319
-61,681
-77% -$43.2K
AYTU icon
9155
AYTU BioPharma
AYTU
$25.2M
$7K ﹤0.01%
+3
New +$20.6K
KTOVW
9156
DELISTED
Kitov Pharma Ltd. Warrants
KTOVW
$7K ﹤0.01%
+11,188
New +$8.03K
BHACR
9157
DELISTED
Barington/Hilco Acquisition Corp. Rights
BHACR
$7K ﹤0.01%
+20,388
New +$6.05K
CPHI icon
9158
China Pharma Holdings
CPHI
$37.6M
$6K ﹤0.01%
+37
New +$6.61K
NBSE
9159
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$6K ﹤0.01%
70
-5
-7% -$744
PKD
9160
DELISTED
Parker Drilling Company
PKD
$6K ﹤0.01%
667
-684
-51% -$10.4K
IMNP
9161
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$6K ﹤0.01%
16,858
+2,607
+18% +$1.24K
OREX
9162
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
$6K ﹤0.01%
30,900
-36,400
-54% -$33.6K
CLRBZ
9163
DELISTED
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
$5K ﹤0.01%
12,272
-195,528
-94% -$95.8K
CELGZ
9164
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$5K ﹤0.01%
13,481
-16,246
-55% -$10.6K
JRJR
9165
DELISTED
JRjr33, Inc.
JRJR
$4K ﹤0.01%
+29,856
New +$4.83K
EPIX
9166
DELISTED
ESSA Pharma
EPIX
$3K ﹤0.01%
792
-2,639
-77% -$11K
BTX.WS
9167
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$3K ﹤0.01%
27,663
-2,244
-8% -$328
KODK.WS
9168
DELISTED
Eastman Kodak Company
KODK.WS
$3K ﹤0.01%
16,343
-30,154
-65% -$13.3K
DYN.WS.A
9169
DELISTED
Dynegy Inc.
DYN.WS.A
$3K ﹤0.01%
+11,631
New +$2.58K
ACERW
9170
DELISTED
Acer Therapeutics Inc Warrant
ACERW
$3K ﹤0.01%
+1,001,125
New +$7.91K
NBSE
9171
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2K ﹤0.01%
26
-37
-59% -$5.5K
NBSE
9172
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2K ﹤0.01%
+27
New +$4.01K
LMFAW
9173
DELISTED
LM Funding America, Inc. Warrant
LMFAW
$2K ﹤0.01%
17,396
+2,717
+19% +$317
JSYNW
9174
DELISTED
Jensyn Acquistion Corp. Warrants
JSYNW
$2K ﹤0.01%
+10,597
New +$2.35K
CYHHZ
9175
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
172,296
+133,611
+345% +$989

Similar funds

Jeff Yass's Q1 2018 Portfolio in Review

As of Q1 2018, Jeff Yass held 10,979 positions worth $281B, down 1% from $283B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q1 2018 filing shows 1,821 new, 3,804 increased, 3,502 reduced and 1,753 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M. The largest sale was Apple, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 2.6% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Jeff Yass's largest Q1 2018 buy was iShares 0-1 Year Treasury Bond ETF: 3,090,594 shares worth $341M.
  • Jeff Yass added most to Meta Platforms (Facebook) in Q1 2018, an estimated $944M increase.
  • Jeff Yass's biggest Q1 2018 reduction was Apple, cutting an estimated $1.29B.
  • Jeff Yass fully exited iShares MSCI Japan ETF in Q1 2018, selling an estimated $84.1M.
  • Jeff Yass's ten largest holdings make up 27% of its $281B portfolio in Q1 2018.
  • Jeff Yass opened 1,821 new positions and closed 1,753 in Q1 2018.
  • Jeff Yass's portfolio value fell 1% quarter-over-quarter to $281B.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.